NMPA Issues Export Drug Certification Rules, Expanding Scope and Validity
Policy / Regulatory

NMPA Issues Export Drug Certification Rules, Expanding Scope and Validity

Bayer's HYRNUO Wins FDA Approval for HER2-Mutated Lung Cancer
CompanyDrug

Bayer’s HYRNUO Wins FDA Approval for HER2-Mutated Lung Cancer

Johnson & Johnson China PINS Head Alex He to Depart, Driving Leadership Transition Amid Key NRDL Product Success
Company

Johnson & Johnson China PINS Head Alex He to Depart, Driving Leadership Transition Amid Key NRDL Product Success

3SBio's Mandi Spin-Off Targets HKEX IPO as Hair Health Leader
CompanyDeals

3SBio’s Mandi Spin-Off Targets HKEX IPO as Hair Health Leader

GE HealthCare to Acquire Intelerad for $2.3B, Expanding Cloud-Enabled Imaging
CompanyDeals

GE HealthCare to Acquire Intelerad for $2.3B, Expanding Cloud-Enabled Imaging

Sinovac Receives Nasdaq Delisting Notice Over Late 20-F Filing
Company

Sinovac Receives Nasdaq Delisting Notice Over Late 20-F Filing

Pien Tze Huang's PZH2108 Cancer Pain Drug Enrolls First Phase IIa Patient
CompanyDrug

Pien Tze Huang’s PZH2108 Cancer Pain Drug Enrolls First Phase IIa Patient

Abbott to Acquire Exact Sciences for $21B, Entering Cancer Diagnostics Leadership
CompanyDeals

Abbott to Acquire Exact Sciences for $21B, Entering Cancer Diagnostics Leadership

Henlius Serplulimab Wins BTD for Gastric Cancer Perioperative Treatment, a China First
CompanyDrug

Henlius Serplulimab Wins BTD for Gastric Cancer Perioperative Treatment, a China First

FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors
Policy / Regulatory

FDA Pilot Program Offers Meeting Minute Clarification to Drug Sponsors

Reprogenix Closes RMB 500M Series A+ to Advance Diabetes Cell Therapy Pipeline
Others

Reprogenix Closes RMB 500M Series A+ to Advance Diabetes Cell Therapy Pipeline

Pfizer's Hympavzi Wins China Approval as First Weekly Non‑Factor Hemophilia Therapy
CompanyDrug

Pfizer’s Hympavzi Wins China Approval as First Weekly Non‑Factor Hemophilia Therapy